Division of Infectious Diseases, University of Louisville, Louisville, KY.
Baylor College of Medicine and Michael E. DeBakey VA Medical Center, Houston, TX.
Chest. 2020 Nov;158(5):1896-1911. doi: 10.1016/j.chest.2020.05.598. Epub 2020 Jun 16.
Community-acquired pneumonia (CAP) guidelines have improved the treatment and outcomes of patients with CAP, primarily by standardization of initial empirical therapy. But current society-published guidelines exclude immunocompromised patients.
There is no consensus regarding the initial treatment of immunocompromised patients with suspected CAP.
This consensus document was created by a multidisciplinary panel of 45 physicians with experience in the treatment of CAP in immunocompromised patients. The Delphi survey methodology was used to reach consensus.
The panel focused on 21 questions addressing initial management strategies. The panel achieved consensus in defining the population, site of care, likely pathogens, microbiologic workup, general principles of empirical therapy, and empirical therapy for specific pathogens.
This document offers general suggestions for the initial treatment of the immunocompromised patient who arrives at the hospital with pneumonia.
社区获得性肺炎 (CAP) 指南通过标准化初始经验性治疗,改善了 CAP 患者的治疗效果和结局。但目前已发布的指南并未将免疫功能低下患者纳入其中。
免疫功能低下疑似 CAP 患者的初始治疗方法尚无共识。
该共识文件由 45 名具有免疫功能低下患者 CAP 治疗经验的多学科专家小组制定。采用德尔菲调查法达成共识。
专家组重点关注了 21 个初始管理策略问题。专家组就定义人群、治疗地点、可能病原体、微生物学检查、经验性治疗的一般原则以及针对特定病原体的经验性治疗等方面达成了共识。
本文为免疫功能低下的肺炎住院患者提供了初始治疗的一般建议。